ARBITEL CT 40/6.25 TAB

About

ARBITEL CT 40/6.25 TAB combines Telmisartan, an angiotensin II receptor blocker (ARB), with Chlorthalidone, a long-acting thiazide-like diuretic. Telmisartan works by blocking the effects of angiotensin II, a potent vasoconstrictor, leading to relaxation of blood vessels and reduced blood pressure. Chlorthalidone enhances the excretion of sodium and water from the body, further contributing to blood pressure reduction. This specific formulation, with lower doses of both components, is designed for patients who require effective blood pressure control with potentially fewer dose-related side effects, or as an initial therapy for essential hypertension. It offers a synergistic approach to managing hypertension, aiming to achieve target blood pressure levels and reduce cardiovascular risks.

Uses

• Treatment of essential hypertension.
• Initial therapy for mild to moderate hypertension.
• Management of hypertension in patients requiring combination therapy.
• Reduction of overall cardiovascular risk.

Directions For Use

Take orally once daily, with or without food, as directed by your physician.

Benefits

• Effective blood pressure control with lower doses.
• Reduces the risk of cardiovascular events.
• Improved tolerability profile due to lower component dosages.
• Convenient once-daily administration.
• Synergistic action for comprehensive hypertension management.
• Suitable for patients needing initial combination therapy.

Side Effects

• Dizziness or lightheadedness
• Fatigue
• Headache
• Nausea
• Diarrhea
• Muscle cramps
• Hypotension
• Hypokalemia
• Hyperuricemia
• Hyperglycemia
• Rash or photosensitivity
• Electrolyte imbalances

Safety Measures

• Alcohol - Limit or avoid alcohol as it can intensify the blood pressure-lowering effect, increasing the risk of dizziness and fainting.
• Pregnancy - Contraindicated during pregnancy, especially in the second and third trimesters, due to significant risk of fetal renal dysfunction and mortality.
• Breastfeeding - Not recommended during breastfeeding as both active ingredients can pass into breast milk and may cause adverse effects in the nursing infant.
• Liver - Use with caution in patients with severe hepatic impairment; dose adjustment may be necessary due to altered drug metabolism and excretion.
• Kidney - Use with caution in patients with severe renal impairment; close monitoring of kidney function and electrolytes is essential due to potential for worsening renal function.
• Lung - Generally considered safe for patients with lung conditions; however, monitor for any unusual respiratory symptoms, though not a common side effect.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.